Effect of deep brain stimulation on speech performance in Parkinson's disease

Sabine Skodda, Sabine Skodda

Abstract

Deep brain stimulation (DBS) has been reported to be successful in relieving the core motor symptoms of Parkinson's disease (PD) and motor fluctuations in the more advanced stages of the disease. However, data on the effects of DBS on speech performance are inconsistent. While there are some series of patients documenting that speech function was relatively unaffected by DBS of the nucleus subthalamicus (STN), other investigators reported on improvements of distinct parameters of oral control and voice. Though, these ameliorations of single speech modalities were not always accompanied by an improvement of overall speech intelligibility. On the other hand, there are also indications for an induction of dysarthria as an adverse effect of STN-DBS occurring at least in some patients with PD. Since a deterioration of speech function has more often been observed under high stimulation amplitudes, this phenomenon has been ascribed to a spread of current-to-adjacent pathways which might also be the reason for the sporadic observation of an onset of dysarthria under DBS of other basal ganglia targets (e.g., globus pallidus internus/GPi or thalamus/Vim). The aim of this paper is to review and evaluate reports in the literature on the effects of DBS on speech function in PD.

References

    1. Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S. Speech impairment in a large sample of patients with Parkinson’s disease. Behavioural Neurology. 1998;11(3):131–137.
    1. Duffy JR. Hypokinetic dysarthria. In: Duffy JR, editor. Motor Speech Disorders. St. Louis, Mo, USA: Elsevier; 1995. pp. 187–215.
    1. Mutch WJ, Strudwick A, Roy SK, Downie AW. Parkinson’s disease: disability, review, and management. British Medical Journal. 1986;293(6548):675–677.
    1. Baker KK, Ramig LO, Luschei ES, Smith ME. Thyroarytenoid muscle activity associated with hypophonia in Parkinson's disease and aging. Neurology. 1998;51(6):1592–1598.
    1. Darley FL, Aronson AE, Brown JR. Clusters of deviant speech dimensions in the dysarthrias. Journal of Speech and Hearing Research. 1969;12(3):462–496.
    1. Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research. 1969;12(2):246–269.
    1. Canter GJ. Speech characteristics of patients with Parkinson's disease. I: Intensity, pitch, and duration. The Journal of Speech and Hearing Disorders. 1963;28:221–229.
    1. Canter GJ. Speech characteristics of patients with Parkinson's disease: II. Physiological support for speech. The Journal of Speech and Hearing Disorders. 1965;30:44–49.
    1. De Letter M, Santens P, Van Borsel J. The effects of levodopa on tongue strength and endurance in patients with Parkinson’s disease. Acta Neurologica Belgica. 2003;103(1):35–38.
    1. De Letter M, Santens P, Van Borsel J. The effects of levodopa on word intelligibility in Parkinson’s disease. Journal of Communication Disorders. 2005;38(3):187–196.
    1. De Letter M, Santens P, De Bodt M, Van Maele G, Van Borsel J, Boon P. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson’s disease. Clinical Neurology and Neurosurgery. 2007;109(6):495–500.
    1. De Letter M, Santens P, De Bodt M, Boon P, Van Borsel J. Levodopa-induced alterations in speech rate in advanced Parkinson’s disease. Acta Neurologica Belgica. 2006;106(1):19–22.
    1. Ho AK, Bradshaw JL, Iansek R. For better or worse: the effect of Levodopa on speech in Parkinson’s disease. Movement Disorders. 2008;23(4):574–580.
    1. Gamboa J, Jiménez-Jiménez FJ, Nieto A, et al. Acoustic voice analysis in patients with Parkinson’s disease treated with dopaminergic drugs. Journal of Voice. 1997;11(3):314–320.
    1. Goberman AM, Coelho C. Acoustic analysis of Parkinsonian speech I: speech characteristics and L-Dopa therapy. NeuroRehabilitation. 2002;17(3):237–246.
    1. Baker KK, Ramig LO, Johnson AB, Freed CR. Preliminary voice and speech analysis following fetal dopamine transplants in 5 individuals with Parkinson disease. Journal of Speech, Language, and Hearing Research. 1997;40(3):615–626.
    1. Kompoliti K, Wang QE, Goetz CG, Leurgans S, Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson’s disease. Neurology. 2000;54(2):458–462.
    1. Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. Journal of Neural Transmission. 2010;117(2):197–205.
    1. Dias AE, Barbosa ER, Coracini K, Maia F, Marcolin MA, Fregni F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson’s disease. Acta Neurologica Scandinavica. 2006;113(2):92–99.
    1. Berke GS, Gerratt B, Kreiman J, Jackson K. Treatment of Parkinson hypophonia with percutaneous collagen augmentation. Laryngoscope. 1999;109(8):1295–1299.
    1. Sapir S, Ramig LO, Fox CM. Intensive voice treatment in Parkinson’s disease: lee silverman voice treatment. Expert Review of Neurotherapeutics. 2011;11(6):815–830.
    1. Ransmayr G. Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson’s disease. Journal of Neural Transmission. 2011;118(5):773–781.
    1. Bell DS. Speech functions of the thalamus inferred from the effects of thalamotomy. Brain. 1968;91(4):619–638.
    1. Petrovici JN. Speech disturbances following stereotaxic surgery in ventrolateral thalamus. Neurosurgical Review. 1980;3(3):189–195.
    1. Linhares MN, Tasker RR. Microelectrode-guided thalamotomy for Parkinson’s disease. Neurosurgery. 2000;46(2):390–398.
    1. Canter GJ, Van Lancker DR. Disturbances of the temporal organization of speech following bilateral thalamic surgery in a patient with Parkinson’s disease. Journal of Communication Disorders. 1985;18(5):329–349.
    1. Stracciari A, Guarino M, Cirignotta F, Pazzaglia P. Development of palilalia after stereotaxic thalamotomy in Parkinson’s disease. European Neurology. 1993;33(3):275–276.
    1. Tasker RR, Siqueira J, Hawrylyshyn P, Organ LW. What happened to VIM thalamotomy for Parkinson’s disease? Applied Neurophysiology. 1983;46(1–4):68–83.
    1. Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotactic and Functional Neurosurgery. 1992;58(1–4):14–21.
    1. Buck JF, Cppper IS. Speech problems in parkinsonian patients undergoing anterior choroidal artery occlusion or chemopallidectomy. Journal of the American Geriatrics Society. 1956;4(12):1285–1290.
    1. Ghika J, Ghika-Schmid F, Fankhauser H, et al. Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson’s disease: neuropsychological and neurological side effects: report of four cases and review of the literature. Journal of Neurosurgery. 1999;91(2):313–321.
    1. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson’s disease. The New England Journal of Medicine. 1997;337(15):1036–1042.
    1. Scott R, Gregory R, Hines N, et al. Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson’s disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain. 1998;121(4):659–675.
    1. Barlow SM, Iacono RP, Paseman LA, Biswas A, D'Antonio L. The effects of posteroventral pallidotomy on force and speech aerodynamics in Parkinson's disease. In: Cannito M, Yorston KM, Beukelman DR, editors. Neuromotor Speech Disorders: Nature Assessment and Management. Baltimore, Md, USA: Brooks; 1998. pp. 117–155.
    1. Schulz GM, Peterson T, Sapienza CM, Greer M, Friedman W. Voice and speech characteristics of persons with Parkinson’s disease pre-and post-pallidotomy surgery: preliminary findings. Journal of Speech, Language, and Hearing Research. 1999;42(5):1176–1194.
    1. Schulz GM, Greer M, Friedman W. Changes in vocal intensity in Parkinson’s disease following pallidotomy surgery. Journal of Voice. 2000;14(4):589–606.
    1. Tröster AI, Woods SP, Fields JA, Hanisch C, Beatty WW. Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson’s disease. Brain and Cognition. 2002;50(2):207–217.
    1. Murdoch BE. Surgical approaches to treatment of Parkinson’s disease: implications for speech function. International Journal of Speech-Language Pathology. 2010;12(5):375–384.
    1. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 2006;31:896–898.
    1. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced parkinson disease: a randomized controlled trial. Journal of the American Medical Association. 2009;301(1):63–73.
    1. Voges J, Koulousakis A, Sturm V. Deep brain stimulation for Parkinson’s disease. Acta Neurochirurgica, Supplementum. 2007;97(2):171–184.
    1. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 2012;79:55–65.
    1. Perlmutter JS, Mink JW. Deep brain stimulation. Annual Review of Neuroscience. 2006;29:229–257.
    1. Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. The New England Journal of Medicine. 2001;345(13):956–963.
    1. Piboolnurak P, Lang AE, Lozano AM, et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson’s disease. Movement Disorders. 2007;22(7):990–997.
    1. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Movement Disorders. 2006;21(supplement 14):S290–S304.
    1. Klostermann F, Ehlen F, Vesper J, et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79(5):522–529.
    1. Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B. High-frequency stimulation of the globus pallidus internalis in Parkinson’s disease: a study of seven cases. Journal of Neurosurgery. 1997;87(4):491–498.
    1. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with parkinson’s disease with severe motor fluctuations: a 2-year follow-up review. Journal of Neurosurgery. 1998;89(5):713–718.
    1. Krause M, Fogel W, Heck A, et al. Deep brain stimulation for the treatment of Parkinson’s disease: subthalamic nucleus versus globus pallidus internus. Journal of Neurology Neurosurgery and Psychiatry. 2001;70(4):464–470.
    1. Lyons KE, Wilkinson SB, Tröster AI, Pahwa R. Long-term efficacy of globus pallidus stimulation for the treatment of Parkinson’s disease. Stereotactic and Functional Neurosurgery. 2002;79(3-4):214–220.
    1. Taha JM, Janszen MA, Favre J. Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. Journal of Neurosurgery. 1999;91(1):68–72.
    1. Obwegeser AA, Uitti RJ, Witte RJ, Lucas JA, Turk MF, Wharen RE. Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors. Neurosurgery. 2001;48(2):274–284.
    1. Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79(6):694–699.
    1. Putzke JD, Wharen RE, Wszolek ZK, Turk MF, Strongosky AJ, Uitti RJ. Thalamic deep brain stimulation for tremor-predominant Parkinson’s disease. Parkinsonism and Related Disorders. 2003;10(2):81–88.
    1. Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of bilateral deep-brain stimulation on oral control of patients with Parkinsonism. European Neurology. 2000;44(3):147–152.
    1. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson’s Disease Rating Scale motor examination. Movement Disorders. 1994;9(1):89–91.
    1. Karlsson F, Blomstedt P, Olofsson K, Linder J, Nordh E, van Doorn J. Control of phonatory onset and offset in Parkinson patients following deep brain stimulation of the subthalamic nucleus and caudal zona incerta. Parkinsonism & Related Disorders. 2012;18:824–827.
    1. Dromey C, Bjarnason S. A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson's disease. Parkinson's Disease. 2011;2011796205
    1. Lundgren S, Saeys T, Karlsson F, et al. Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on voice intensity. Parkinson's Disease. 2011;2011:8 pages.658956
    1. Karlsson F, Unger E, Wahlgren S, et al. Deep brain stimulation of caudal zona incerta and subthalamic nucleus in patients with Parkinson's disease: effects on diadochokinetic rate. Parkinson's Disease. 2011;2011:10 pages.605607
    1. Chenausky K, Macauslan J, Goldhor R. Acoustic analysis of PD speech. Parkinson's Disease. 2011;2011:13 pages.435232
    1. Skodda S, Flasskamp A, Schlegel U. Instability of syllable repetition in Parkinson’s disease-Influence of levodopa and deep brain stimulation. Movement Disorders. 2011;26(4):728–730.
    1. Paek SH, Lee JY, Kim HJ, et al. Electrode position and the clinical outcome after bilateral subthalamic nucleus stimulation. Journal of Korean Medical Science. 2011;26:1344–1355.
    1. Robertson LT, St George RJ, Carlson-Kuhta P, Hogarth P, Burchiel KJ, Horak FB. Site of deep brain stimulation and jaw velocity in Parkinson disease. Journal of Neurosurgery. 2011;115:985–994.
    1. Moreau C, Pennel-Ployart O, Pinto S, et al. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson’s disease. Movement Disorders. 2011;26(4):659–663.
    1. Toft M, Dietrichs E. Aggravated stuttering following subthalamic deep brain stimulation in Parkinson’s disease—two cases. BMC Neurology. 2011;11, article 44
    1. Xie Y, Zhang Y, Zheng Z, et al. Changes in speech characters of patients with Parkinson’s disease after bilateral subthalamic nucleus stimulation. Journal of Voice. 2011;25:751–758.
    1. Hartinger M, Tripoliti E, Hardcastle WJ, Limousin P. Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson’s disease using electropalatography: a pilot study. Clinical Linguistics and Phonetics. 2011;25(3):210–230.
    1. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology. 2011;76(1):80–86.
    1. Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson’s disease. Journal of Communication Disorders. 2011;44(1):37–48.
    1. Van Lancker Sidtis D, Rogers T, Godier V, Tagliati M, Sidtis JJ. Voice and fluency changes as a function of speech task and deep brain stimulation. Journal of Speech, Language, and Hearing Research. 2010;53(5):1167–1177.
    1. Hammer MJ, Barlow SM, Lyons KE, Pahwa R. Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson’s disease. Journal of Neurology. 2010;257(10):1692–1702.
    1. Åström M, Tripoliti E, Hariz MI, et al. Patient-specific model-based investigation of speech intelligibility and movement during deep brain stimulation. Stereotactic and Functional Neurosurgery. 2010;88(4):224–233.
    1. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Movement Disorders. 2008;23(16):2377–2383.
    1. Lee VS, Zhou XP, Rahn DA, Wang EQ, Jiang JJ. Perturbation and nonlinear dynamic analysis of acoustic phonatory signal in Parkinsonian patients receiving deep brain stimulation. Journal of Communication Disorders. 2008;41(6):485–500.
    1. Klostermann F, Ehlen F, Vesper J, et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79(5):522–529.
    1. D’Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. Journal of Voice. 2008;22(3):365–372.
    1. Pützer M, Barry WJ, Moringlane JR. Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinson’s disease. Clinical Linguistics and Phonetics. 2008;22(12):957–973.
    1. Törnqvist AL, Schalén L, Rehncrona S. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Movement Disorders. 2005;20(4):416–423.
    1. Pinto S, Gentil M, Krack P, et al. Changes induced by Levodopa and subthalamic nucleus stimulation on Parkinsonian speech. Movement Disorders. 2005;20(11):1507–1515.
    1. Pinto S, Thobois S, Costes N, et al. Subthalamic nucleus stimulation and dysarthria in Parkinson’s disease: a PET study. Brain. 2004;127(3):602–615.
    1. Rousseaux M, Krystkowiak P, Kozlowski O, Özsancak C, Blond S, Destée A. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. Journal of Neurology. 2004;251(3):327–334.
    1. Gentil M, Pinto S, Pollak P, Benabid AL. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain and Language. 2003;85(2):190–196.
    1. Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson’s disease. Journal of Neurology. 2003;250(2):179–187.
    1. Moretti R, Torre P, Antonello RM, et al. ’Speech initiation hesitation’ following subthalamic nucleus stimulation in a patient with Parkinson’s disease. European Neurology. 2003;49(4):251–253.
    1. Gentil M, Chauvin P, Pinto S, Pollak P, Benabid AL. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain and Language. 2001;78(2):233–240.
    1. Dromey C, Kumar R, Lang AE, Lozano AM. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Movement Disorders. 2000;15:1132–1138.
    1. Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of bilateral deep-brain stimulation on oral control of patients with Parkinsonism. European Neurology. 2000;44(3):147–152.
    1. Gentil M, Tournier CL, Pollak P, Benabid AL. Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson’s disease. European Neurology. 1999;42(3):136–140.
    1. Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL. Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. Journal of Neurology Neurosurgery and Psychiatry. 1999;67(3):329–333.
    1. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinsonian’s disease. The New England Journal of Medicine. 1998;339(16):1105–1111.
    1. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. The New England Journal of Medicine. 2003;349(20):1925–1934.
    1. Farrell A, Theodoros D, Ward E, Hall B, Silburn P. Effects of neurosurgical management of Parkinson’s disease on speech characteristics and oromotor function. Journal of Speech, Language, and Hearing Research. 2005;48(1):5–20.
    1. Santens P, De Letter M, Van Borsel J, De Reuck J, Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson’s disease. Brain and Language. 2003;87(2):253–258.
    1. Wang E, Verhagen Metman L, Bakay R, Arzbaecher J, Bernard B. The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson’s disease—a preliminary report. Clinical Linguistics and Phonetics. 2003;17(4-5):283–289.
    1. McIntyre CC, Savasta M, Walter BL, Vitek JL. How does deep brain stimulation work? Present understanding and future questions. Journal of Clinical Neurophysiology. 2004;21(1):40–50.
    1. Critchley EM. Speech disorders of Parkinsonism: a review. Journal of Neurology, Neurosurgery & Psychiatry. 1981;44:751–758.
    1. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56(4):548–551.
    1. Spielman J, Mahler L, Halpern A, Gilley P, Klepitskaya O, Ramig L. Intensive voice treatment (LSVT LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. Journal of Communication Disorders. 2011;44:688–700.
    1. Boertien T, Zrinzo L, Kahan J, et al. Functional imaging of subthalamic nucleus deep brain stimulation in Parkinson’s disease. Movement Disorders. 2011;26:2434–2436.
    1. Rouaud T, Dondaine T, Drapier S, et al. Pallidal stimulation in advanced Parkinson’s patients with contraindications for subthalamic stimulation. Movement Disorders. 2010;25(12):1839–1846.
    1. Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Movement Disorders. 2008;23(3):416–421.
    1. Pahwa R, Lyons KE, Wilkinson SB, et al. Long-term evaluation of deep brain stimulation of the thalamus. Journal of Neurosurgery. 2006;104(4):506–512.
    1. Dowsey-Limousin P. Postoperative management of vin DBS for tremor. Movement Disorders. 2002;17(supplement 3):S208–S211.
    1. Frost E, Tripoliti E, Hariz MI, Pring T, Limousin P. Self-perception of speech changes in patients with Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. International Journal of Speech-Language Pathology. 2010;12(5):399–404.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj